title: Avoiding the bad and enhancing the good of soy supplements in breast cancer.
authors.affiliation: Department of Oncology, Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC. vcj2@georgetown.edu.
authors.forename: V Craig
authors.initials: VC
authors.lastname: Jordan
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000378:metabolism*; D019587:Dietary Supplements / Q000009:adverse effects*; D005260:Female; D019833:Genistein / Q000097:blood*; D006801:Humans; D051497:Receptor, Fibroblast Growth Factor, Type 2 / Q000378:metabolism*; D030262:Soybean Proteins / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D030262:Soybean Proteins; D019833:Genistein; C496353:FGFR2 protein, human; D051497:Receptor, Fibroblast Growth Factor, Type 2